Clinical trial shows CRISPR gene editing has exciting potential to treat a rare form of blindness

FHS
May 8, 2024
2:28 pm

A recent study published in The New England Journal of Medicine investigated the potential use of gene editing to correct a congenital retinal degeneration called CEP290 that causes early-onset vision loss.

FDA raises cleaning and quality concerns at another Ipca Laboratories manufacturing site in India

Indian manufacturer Ipca Laboratories has another production site under the FDA’s microscope after an inspection revealed several quality issues. The FDA identified eight overarching issues

July 7, 2023

Telemedicine boosts equitable access to endocrinology care for patients with diabetes and heart disease

Widespread availability of telemedicine during the pandemic led to more equitable access to endocrinology care for patients with type 2 diabetes and heart disease, according

June 3, 2024

Microsoft’s Peter Lee says ChatGPT shouldn’t be used for initial diagnosis

SAN FRANCISCO — Surging interest in generative AI among medical professionals since ChatGPT’s launch is perhaps a testament to its potential — but it could

May 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.